Skip to content

Comparison of Conventional and Cooled Radiofrequency Ablation in Knee Osteoarthritis

Comparison of the Effectiveness of Conventional and Cooled Radiofrequency Ablation in Advanced Knee Osteoarthritis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06863181
Enrollment
26
Registered
2025-03-07
Start date
2025-02-01
Completion date
2025-11-12
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

The aim of this study was to examine and compare the effects of conventional and cooled radiofrequency ablation on pain and disability levels in patients with knee pain resistant to other treatments due to knee osteoarthritis.

Interventions

DEVICERadiofrequency ablation

Genicular nerve neurolysis with heat

Sponsors

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Knee pain lasting more than 6 months * Age between 50 and 80 * Diagnosis of radiographically proven grade III or IV knee osteoarthritis according to the Kellgren-Lawrence Grading Scale, marked narrowing of the medial compartment of the tibiofemoral joint space * Presence of pain resistant to conservative treatment * Exercise * Physical therapy agents * Use of oral anti-inflammatory agents

Exclusion criteria

* History of trauma to the knee area * History of knee surgery * Presence of systemic inflammatory disease affecting the knee joint * Presence of peripheral neuropathy or radiculopathy * Pregnancy * Hemodynamic instability * Presence of skin or soft tissue infection at the injection site * Refusal to participate in the study * Presence of acute knee pain with accompanying inflammatory findings * Presence of a serious psychiatric disorder or neurological disease Having received an intra-articular injection within the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)Patients will select their pain from 10 mm scale

Secondary

MeasureTime frameDescription
Western Ontario and McMaster Universities Arthritis Index (WOMAC)Before treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)This scale about patient's disability due to knee osteoarthritis
5-Point Likert Patient Satisfaction ScaleBefore treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)'0' =I am not happy at all, '5'=I am very pleased
Change in frequency of analgesic useBefore treatment (0. week), 4 weeks after treatment (4.week), 12 weeks after treatment (12.week)How many analgesic did use in past week?

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026